Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 30 of MiNK Therapeutics, Inc.'s SEC filings and found 1 convertible, 1 ATM program and 3 shelf registrations on file for INKT. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
GOSSGossamer Bio, Inc.
BOLDBoundless Bio, Inc.
XLOXilio Therapeutics, Inc.
CLNNClene Inc.
HRTXHeron Therapeutics, Inc.
RNTXRein Therapeutics Inc.
RNXTRenovoRx, Inc.
OSTXOS Therapies Incorporated
XBITXBiotech Inc.
VRCAVerrica Pharmaceuticals Inc.
ELOXEloxx Pharmaceuticals, Inc.
IBIOiBio, Inc.
PLRXPliant Therapeutics, Inc.
HOWLWerewolf Therapeutics, Inc.
SPROSpero Therapeutics, Inc.